For more information on Ulcerative Colitis and Asacol visit www.asacol.com.
Asacol is proven to treat flare-ups
Asacol is proven to treat mild to moderate flare-ups of ulcerative colitis. In a six-week clinical study of flare-ups, Asacol was evaluated for its ability to reduce ulcerative colitis symptoms, including rectal bleeding, number of bowel movements, and abdominal pain. After three weeks of therapy, rectal bleeding and number of bowel movements were reduced.
 Asacol is proven to extend your time in remission
Asacol is also proven to maintain remission. In a six-month study, Asacol extended patients' time in remission when taken continuously at the maintenance dose, as compared to placebo (sugar pill).
Talk with your healthcare professional to see if remission therapy is right for you. Responses to remission therapy can vary. In addition, drug therapy may cause side effects.
Ulcerative colitis rarely goes into permanent remission. The risk of flare-ups can be substantially reduced by continued use of Asacol at the maintenance dose as directed by your healthcare professional.
Who should not take Asacol
You should not take Asacol if you are allergic to Asacol or to salicylates such as aspirin. Tell your healthcare professional if you have kidney problems or a history of kidney disease. It is recommended that all people have their kidney functions tested prior to starting Asacol tablets and periodically while on Asacol therapy. Some serious side effects may occur. If you have questions about taking Asacol, please talk to your healthcare professional.
Asacol is generally well tolerated. In studies of flare-ups, some people taking Asacol reported headache, abdominal pain, general pain, rash, upset stomach, and worsening of ulcerative colitis symptoms. In a six-month maintenance study, people reported headache, runny nose, general pain, sore throat, infection, and nervousness.
For more information on Asacol, please see Product Information (PDF)
Can't view the PDF?
Click here to download Adobe Acrobat.
|
